Mazor Robotics Ltd., a developer of innovative guidance systems and complementary products, announced today that it has received the first order for its Renaissance system since the commercial launch of the brain surgery module.
The system was sold to Bryan Medical Center in Lincoln, NE and will be utilized for spine and brain procedures. Bryan Medical Center is a 640-bed, not-for-profit, locally owned and governed health care organization serving patients from throughout Nebraska, as well as parts of Kansas, Iowa, South Dakota and other states in the region.
“The first order for Renaissance with our brain surgery module is a new milestone for Mazor Robotics. The value proposition offered to our customers enabled our team to achieve the first system placement in the U.S., less than three months after we commercially launched the brain application,” commented Ori Hadomi, Chief Executive Officer. “The versatility of the Renaissance system enables surgeons and hospital administrators to deploy a single proven system for both brain and spine procedures.”
The Company commercially launched the brain application at the American Association of Neurological Surgeons (AANS) annual meeting in April 2014. Renaissance’s brain module is primarily used to assist with Deep Brain Stimulation (DBS) procedures to treat movement disorders, such as Parkinson’s disease. Three other hospitals, including Littleton Adventist (Littleton, CO), were utilizing the brain application during a pre-launch testing period and continue to use the system for brain surgeries.
About Mazor
Mazor Robotics is dedicated to the development and marketing of innovative surgical guidance systems and complementary products that provide a safer surgical environment for patients, surgeons, and operating room staff. Mazor Robotics’ flagship product, Renaissance®, is a state-of-the-art surgical guidance system that enables surgeons to conduct spine surgeries in an accurate and secure manner. Mazor Robotics systems have been successfully used in the placement of over 45,000 implants worldwide. Numerous peer-reviewed publications and presentations at leading scientific conferences have validated the accuracy, usability, and clinical advantages of Mazor Robotics technology.
Source: http://mazorrobotics.com/